(E)-1-(4-(2-Methyl-6-((5-(3-methylstyryl)thiazol-2-yl)amino)pyrimidin-4-yl)piperazin-1-yl)hex-5-yn-1-one

ID: ALA4649252

PubChem CID: 156020784

Max Phase: Preclinical

Molecular Formula: C27H30N6OS

Molecular Weight: 486.65

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCCCC(=O)N1CCN(c2cc(Nc3ncc(/C=C/c4cccc(C)c4)s3)nc(C)n2)CC1

Standard InChI:  InChI=1S/C27H30N6OS/c1-4-5-6-10-26(34)33-15-13-32(14-16-33)25-18-24(29-21(3)30-25)31-27-28-19-23(35-27)12-11-22-9-7-8-20(2)17-22/h1,7-9,11-12,17-19H,5-6,10,13-16H2,2-3H3,(H,28,29,30,31)/b12-11+

Standard InChI Key:  DGCBTTMLYPMYQE-VAWYXSNFSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   19.5682  -24.6377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5820  -23.8229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3015  -23.4269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3112  -22.6121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6160  -22.1874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8965  -22.5833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8763  -23.4040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2014  -22.1627    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2212  -21.3482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5160  -20.9154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7968  -21.3113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.7869  -22.1319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4872  -22.5558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1017  -20.8907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3875  -21.2837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6866  -20.8600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9725  -21.2530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2756  -20.8295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5764  -20.4089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1182  -20.0759    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.0253  -22.2149    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0426  -21.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3860  -20.9059    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.6576  -20.1358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4724  -20.1515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7094  -20.9300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1912  -19.4647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5392  -18.7253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0729  -18.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4251  -17.3175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9594  -16.6468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1442  -16.7148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7968  -17.4591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2645  -18.1267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9827  -17.5303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  2  0
  3  4  1  0
  5  4  2  0
  6  5  1  0
  7  6  2  0
  2  7  1  0
  6  8  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 11 12  1  0
 13 12  1  0
  8 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  3  0
 14 20  2  0
 21  4  1  0
 22 21  1  0
 23 22  1  0
 23 24  1  0
 25 24  2  0
 26 25  1  0
 22 26  2  0
 27 24  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 33 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4649252

    ---

Associated Targets(Human)

ABL1 Tclin Cereblon/BCR/ABL (220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 486.65Molecular Weight (Monoisotopic): 486.2202AlogP: 4.92#Rotatable Bonds: 8
Polar Surface Area: 74.25Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.83CX Basic pKa: 6.49CX LogP: 6.09CX LogD: 6.04
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.36Np Likeness Score: -1.62

References

1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y..  (2020)  Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects.,  63  (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967]

Source